Literature DB >> 21304054

Genetic polymorphisms in DNA double-strand break repair genes XRCC5, XRCC6 and susceptibility to hepatocellular carcinoma.

Rui Li1, Yuan Yang, Yu An, Yun Zhou, Yanhong Liu, Qing Yu, Daru Lu, Hongyang Wang, Li Jin, Weiping Zhou, Ji Qian, Yin Yao Shugart.   

Abstract

Environmental risk factors cause DNA damages. Imprecise DNA repair leads to chromosome aberrations, genome destabilization and hepatocarcinogenesis. Ku is a key DNA double-strand break repair protein. We hypothesized that the genetic variants in Ku subunits encoding genes, XRCC5/XRCC6, may contribute to hepatocellular carcinoma (HCC) susceptibility. We genotyped 13 common single nucleotide polymorphisms (SNPs) in XRCC5 and XRCC6 and evaluated their associations with HCC risk in 689 pathologically confirmed cases and 690 cancer-free controls from a Chinese population. We found that a significantly reduced risk for HCC was associated with XRCC5 rs16855458 [odds ratio (OR)=0.59; 95% confidence interval (CI)=0.43-0.81; CA+AA versus CC] and a significantly increased risk for HCC was associated with XRCC5 rs9288516 (OR=2.02; 95% CI=1.42-2.86; TA+AA versus TT) even after Bonferroni correction (Pcorrected=0.026 and 0.002, respectively). The effects of rs16855458 (OR=0.57; 95% CI=0.37-0.86, P=0.008) and rs9288516 (OR=1.86; 95% CI=1.19-2.90, P=0.007) were more significant in hepatitis B surface antigen-infected subjects than non-infected subjects. The haplotype-based analysis revealed that in XRCC5, AA in block 1 (OR=0.63; 95% CI=0.48-0.83) and CGGTT in block 2 (OR=0.52; 95% CI=0.39-0.69) were associated with decreased HCC risk (Pcorrected=0.013 and <0.001, respectively). The aforementioned two SNPs exhibited a significant cumulative risk effect (Ptrend<0.001). Additionally, potential interaction among XRCC5 rs9288516 and rs2267437, rs5751131 in XRCC6 was indicated by the multifactor dimensionality reduction analysis. In conclusion, XRCC5 variants may play a role in determining individual's HCC susceptibility, which warranted validation in larger studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21304054     DOI: 10.1093/carcin/bgr018

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  18 in total

1.  Quantitative assessment of the association between XRCC6 C1310G polymorphism and cancer risk.

Authors:  Hong Jiang; Yun Lin; Chang-qing Yang; Qi Li; Jinhong Luo; Ying Zhou; Junli Xue; Wei Wei; Yong Gao
Journal:  Tumour Biol       Date:  2012-12-28

2.  Susceptibility to gastric cancer and polymorphisms of insertion/deletion at the intron 3 of the XRCC4 and VNTR at the promoter region of the XRCC5.

Authors:  Mostafa Saadat; Samira Pashaei; Foroozan Amerizade
Journal:  Pathol Oncol Res       Date:  2014-12-20       Impact factor: 3.201

Review 3.  Association between the XRCC6 Promoter rs2267437 polymorphism and cancer risk: evidence based on the current literature.

Authors:  Haitao Xu; Peng Zou; Pin Chen; Lin Zhao; Peng Zhao; Ailin Lu
Journal:  Genet Test Mol Biomarkers       Date:  2013-06-08

4.  Telomere maintenance genes SIRT1 and XRCC6 impact age-related decline in telomere length but only SIRT1 is associated with human longevity.

Authors:  Sangkyu Kim; Xiuhua Bi; Malwina Czarny-Ratajczak; Jianliang Dai; David A Welsh; Leann Myers; Michael A Welsch; Katie E Cherry; Jonathan Arnold; Leonard W Poon; S Michal Jazwinski
Journal:  Biogerontology       Date:  2011-10-05       Impact factor: 4.277

5.  Role of polymorphic XRCC6 (Ku70)/XRCC7 (DNA-PKcs) genes towards susceptibility and prognosis of lung cancer patients undergoing platinum based doublet chemotherapy.

Authors:  Amrita Singh; Navneet Singh; Digambar Behera; Siddharth Sharma
Journal:  Mol Biol Rep       Date:  2018-02-03       Impact factor: 2.316

6.  Analysis of difference of association between polymorphisms in the XRCC5, RPA3 and RTEL1 genes and glioma, astrocytoma and glioblastoma.

Authors:  Tianbo Jin; Yuan Wang; Gang Li; Shuli Du; Hua Yang; Tingting Geng; Peng Hou; Yongkuan Gong
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

7.  Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits.

Authors:  Jens U Marquardt; Daekwan Seo; Jesper B Andersen; Matthew C Gillen; Myoung Soo Kim; Elizabeth A Conner; Peter R Galle; Valentina M Factor; Young Nyun Park; Snorri S Thorgeirsson
Journal:  J Hepatol       Date:  2013-10-26       Impact factor: 25.083

8.  Age-Specific Gene Expression Profiles of Rhesus Monkey Ovaries Detected by Microarray Analysis.

Authors:  Hengxi Wei; Xiangjie Liu; Jihong Yuan; Li Li; Dongdong Zhang; Xinzheng Guo; Lin Liu; Shouquan Zhang
Journal:  Biomed Res Int       Date:  2015-09-02       Impact factor: 3.411

Review 9.  Association between the XRCC6 polymorphisms and cancer risks: a systematic review and meta-analysis.

Authors:  Jing Jia; Juan Ren; Dongmei Yan; Long Xiao; Ruifen Sun
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

10.  Alternative splicing of FBP-interacting repressor coordinates c-Myc, P27Kip1/cyclinE and Ku86/XRCC5 expression as a molecular sensor for bleomycin-induced DNA damage pathway.

Authors:  Bahityar Rahmutulla; Kazuyuki Matsushita; Mamoru Satoh; Masanori Seimiya; Sachio Tsuchida; Shuji Kubo; Hideaki Shimada; Masayuki Ohtsuka; Masaru Miyazaki; Fumio Nomura
Journal:  Oncotarget       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.